Mythocondro, a non-animal-sourced chondroitin sulfate ingredient from Gnosis S.p.A. (Desio, Italy), has received a “no objections” response from FDA for Generally Recognized as Safe (GRAS) status for safe use in food and beverage.
Photo © iStockphoto.com/Raycat
Mythocondro, a non-animal-sourced chondroitin sulfate ingredient from Gnosis S.p.A. (Desio, Italy), has received a “no objections” response from FDA for Generally Recognized as Safe (GRAS) status for safe use in food and beverage.
The ingredient is produced via a fermentation-based manufacturing process. Due to its origins, the company contends that Mythocondro sidesteps product-of-origin and adulteration questions that face much of the animal-source chondroitin sulfate market. The ingredient was introduced last fall during SupplySide West. The ingredient is also a finalist in this year’s NutraIngredients Awards, which will be announced during the upcoming Vitafoods Europe trade show in May.
HHS announces restructuring plans to consolidate divisions and downsize workforce
Published: March 27th 2025 | Updated: March 27th 2025According to the announcement, the restructuring will save taxpayers $1.8 billion per year by reducing the workforce by 10,000 full-time employees and consolidating the department’s 28 divisions into 15 new divisions.